Literature DB >> 12782665

What is the real role of antimicrobial polypeptides that can mediate several other inflammatory responses?

Peter Elsbach1.   

Abstract

Antimicrobial peptides are effector molecules of innate immunity with microbicidal and pro- or anti-inflammatory activities. Their role is now widening following evidence that one such multifunctional peptide, LL-37, induces angiogenesis, a process essential for host defense, wound healing, and tissue repair.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12782665      PMCID： PMC156112          DOI： 10.1172/JCI18761

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


  14 in total

Review 1.  Structure and biology of cathelicidins.

Authors:  M Zanetti; R Gennaro; M Scocchi; B Skerlavaj
Journal:  Adv Exp Med Biol       Date:  2000       Impact factor: 2.622

2.  Angiogenin: an antimicrobial ribonuclease.

Authors:  Tomas Ganz
Journal:  Nat Immunol       Date:  2003-03       Impact factor: 25.606

3.  Innate antimicrobial peptide protects the skin from invasive bacterial infection.

Authors:  V Nizet; T Ohtake; X Lauth; J Trowbridge; J Rudisill; R A Dorschner; V Pestonjamasp; J Piraino; K Huttner; R L Gallo
Journal:  Nature       Date:  2001-11-22       Impact factor: 49.962

Review 4.  Therapeutic potential of the bactericidal/permeability-increasing protein.

Authors:  Ofer Levy
Journal:  Expert Opin Investig Drugs       Date:  2002-02       Impact factor: 6.206

5.  Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein.

Authors:  O Levy; S Martin; E Eichenwald; T Ganz; E Valore; S F Carroll; K Lee; D Goldmann; G M Thorne
Journal:  Pediatrics       Date:  1999-12       Impact factor: 7.124

6.  Host defense functions of proteolytically processed and parent (unprocessed) cathelicidins of rabbit granulocytes.

Authors:  Kol A Zarember; Seth S Katz; Brian F Tack; Laurence Doukhan; Jerrold Weiss; Peter Elsbach
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

7.  Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds.

Authors:  A M Cole; J Shi; A Ceccarelli; Y H Kim; A Park; T Ganz
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

8.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis.

Authors:  Peck Y Ong; Takaaki Ohtake; Corinne Brandt; Ian Strickland; Mark Boguniewicz; Tomas Ganz; Richard L Gallo; Donald Y M Leung
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

9.  Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group.

Authors:  M Levin; P A Quint; B Goldstein; P Barton; J S Bradley; S D Shemie; T Yeh; S S Kim; D P Cafaro; P J Scannon; B P Giroir
Journal:  Lancet       Date:  2000-09-16       Impact factor: 79.321

10.  Phagocytin: a bactericidal substance from polymorphonuclear leucocytes.

Authors:  J G HIRSCH
Journal:  J Exp Med       Date:  1956-05-01       Impact factor: 14.307
View more
  29 in total

Review 1.  Nonmammalian vertebrate antibiotic peptides.

Authors:  P Síma; I Trebichavský; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

2.  Midkine and pleiotrophin have bactericidal properties: preserved antibacterial activity in a family of heparin-binding growth factors during evolution.

Authors:  Sara L Svensson; Mukesh Pasupuleti; Björn Walse; Martin Malmsten; Matthias Mörgelin; Camilla Sjögren; Anders I Olin; Mattias Collin; Artur Schmidtchen; Ruth Palmer; Arne Egesten
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

Review 3.  Peptide antimicrobial agents.

Authors:  Håvard Jenssen; Pamela Hamill; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

Review 4.  Midkine in host defence.

Authors:  A Gela; S Jovic; S L Nordin; A Egesten
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 5.  Host defense peptides in wound healing.

Authors:  Lars Steinstraesser; Till Koehler; Frank Jacobsen; Adrien Daigeler; Ole Goertz; Stefan Langer; Marco Kesting; Hans Steinau; Elof Eriksson; Tobias Hirsch
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

6.  C-terminal peptides of tissue factor pathway inhibitor are novel host defense molecules.

Authors:  Praveen Papareddy; Martina Kalle; Gopinath Kasetty; Matthias Mörgelin; Victoria Rydengård; Barbara Albiger; Katarina Lundqvist; Martin Malmsten; Artur Schmidtchen
Journal:  J Biol Chem       Date:  2010-06-30       Impact factor: 5.157

Review 7.  Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications.

Authors:  William K K Wu; Guangshun Wang; Seth B Coffelt; Aline M Betancourt; Chung W Lee; Daiming Fan; Kaichun Wu; Jun Yu; Joseph J Y Sung; Chi H Cho
Journal:  Int J Cancer       Date:  2010-10-15       Impact factor: 7.396

8.  Proteolysis of human thrombin generates novel host defense peptides.

Authors:  Praveen Papareddy; Victoria Rydengård; Mukesh Pasupuleti; Björn Walse; Matthias Mörgelin; Anna Chalupka; Martin Malmsten; Artur Schmidtchen
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

9.  Comparative in vivo infection models yield insights on early host immune response to Campylobacter in chickens.

Authors:  Kieran G Meade; Fernando Narciandi; Sarah Cahalane; Carla Reiman; Brenda Allan; Cliona O'Farrelly
Journal:  Immunogenetics       Date:  2008-12-12       Impact factor: 2.846

10.  Antimicrobial activity of human prion protein is mediated by its N-terminal region.

Authors:  Mukesh Pasupuleti; Markus Roupe; Victoria Rydengård; Krystyna Surewicz; Witold K Surewicz; Anna Chalupka; Martin Malmsten; Ole E Sörensen; Artur Schmidtchen
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.